In addition, breast cancer patients with high expression of ANLN showed significantly poorer overall survival (Magnusson et al., 2016), recurrence as well as higher expression of proliferation genes (all 17 tested in (Thapa and Wilson, 2016)). The gene discussed is ANLN; the disease is breast carcinoma.